Fca Corp Amgen Inc Transaction History

Fca Corp

$305 Million
Q2 2024

A detailed history of Fca Corp transactions in Amgen Inc stock. As of the latest transaction made, Fca Corp holds 17,969 shares of AMGN stock, worth $5.68 Million. This represents 1.84% of its overall portfolio holdings.

Number of Shares

17,969

Previous 17,807 0.91%

Holding current value

$5.68 Million

Previous $5.06 Million 10.9%

% of portfolio

1.84%

Previous 1.68%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $42,565 - $51,728	162 Added 0.91%	17,969 $5.61 Million
Q1 2024 May 08, 2024	BUY	$268.87 - $324.56 $44,363 - $53,552	165 Added 0.94%	17,807 $5.06 Million
Q4 2023 Feb 08, 2024	BUY	$255.7 - $288.46 $5,369 - $6,057	21 Added 0.12%	17,642 $5.08 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $123,537 - $153,374	565 Added 3.31%	17,621 $4.74 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $56,781 - $67,143	-265 Reduced 1.53%	17,056 $3.79 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $368,940 - $449,676	1,634 Added 10.42%	17,321 $4.19 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $23,361 - $29,683	102 Added 0.65%	15,687 $4.12 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $25,812 - $29,112	115 Added 0.74%	15,585 $3.51 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $45,680 - $50,834	-198 Reduced 1.26%	15,470 $3.76 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $17,541 - $19,405	80 Added 0.51%	15,668 $3.79 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $417,648 - $477,960	-2,100 Reduced 11.87%	15,588 $3.51 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $24,835 - $29,097	117 Added 0.67%	17,688 $3.76 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $206,484 - $229,079	-884 Reduced 4.79%	17,571 $4.28 Million
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $16,199 - $18,877	-73 Reduced 0.39%	18,455 $4.59 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $186,303 - $221,853	861 Added 4.87%	18,528 $4.26 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $186,312 - $207,194	-794 Reduced 4.3%	17,667 $4.49 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $989 - $1,213	-5 Reduced 0.03%	18,461 $4.35 Million
Q1 2020 May 20, 2020	BUY	$182.24 - $241.7 $140,871 - $186,834	773 Added 4.37%	18,466 $3.74 Million
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $7,189 - $9,241	38 Added 0.22%	17,693 $4.27 Million
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $145,381 - $174,197	-835 Reduced 4.52%	17,655 $3.42 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $124,191 - $145,580	745 Added 4.2%	18,490 $3.41 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $18,991 - $21,407	-105 Reduced 0.59%	17,745 $3.37 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $17,126 - $19,992	-96 Reduced 0.53%	17,850 $3.48 Million
Q3 2018 Oct 22, 2018	SELL	$185.29 - $208.89 $82,268 - $92,747	-444 Reduced 2.41%	17,946 $3.72 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $3,321 - $3,730	-20 Reduced 0.11%	18,390 $3.4 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $124,022 - $144,936	-732 Reduced 3.82%	18,410 $3.14 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $40,340 - $45,073	239 Added 1.26%	19,142 $3.33 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $3.16 Million - $3.61 Million	18,903	18,903 $3.52 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fca Corp , based on Form 13F filings with the SEC.

News

Stay updated on Fca Corp with notifications on news.

Account